Fact CheckerSign in

NCT04951999Completed

AssocIation of PULSatility and Occurrence of Complications Related to Mechanically Assisted Circulatory Support

Source: ClinicalTrials.gov · Last updated 22 Aug 2025

Brief summary (registry, in English)

The primary objective of this study is to determine whether preserved pulsatility for patients supported by CF-LVAD (continuous flow Left Ventricular Assist Device) is associated with less acquired deficiency of the Von Willebrand factor, a blood glycoprotein involved in hemostasis.

Status (registry)
Completed
Study type
Interventional
Enrollment
27 (actual)
First submitted
14 Jun 2021
Start date
2 Dec 2021
Primary completion date
24 Jul 2024
Lead sponsor
Assistance Publique - Hôpitaux de Paris
NCT number
NCT04951999

What you commit to

  • Study type: Interventional
  • Participants enrolled: 27
  • From 2 Dec 2021 to the primary completion date, 24 Jul 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Heart transplant patients
  • Chronic renal failure patients on dialysis

Other

  • Patients who already had LVAD
  • Patients refusing to give informed consent
  • Patients deprived of liberty or under legal protection (guardianship, curators)
  • Pregnant or breastfeeding women
  • Ongoing participation in another intervention research protocol except LEVOECMO project (NCT04728932) and ANCHOR project (NCT04184635)

Who the study is looking for

  • Patients over 18 years of age
  • Patients for whom a decision to implant a left-sided monoventricular assist has been retained after discussion in the RCP of heart failure, transplantation and circulatory assistance (whatever the therapeutic strategy envisaged: waiting for transplantation, recovery or destination therapy).
  • Patients affiliated to a social security system (beneficiaries or beneficiaries entitled to benefits, excluding AME)
  • Signature of an informed consent by the patient or by the trusted person, or a close relative, if the patient is not able to do so

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Groupement Hospitalier pitié Salpêtrière
Coordinator of this site? Confirm its status
ParisFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.